
Prithvi_Mruthyunjaya
@eyeamprithvi
Associate Professor of Ophthalmology, Director of ocular oncology, director of vitreoretinal surgery fellowship at Stanford University. my tweets are personal
ID: 2462930321
05-04-2014 18:06:17
28 Tweet
378 Followers
163 Following


After 9 mos of #retinoblastoma Tx, 3 yr old Cru is stabilized and back home, racing trucks and riding tricycles. SCI member Prithvi Mruthyunjaya states: "We look forward to watching Cru grow up to become a healthy young man!” stan.md/2CgoZJl Prithvi_Mruthyunjaya Stanford Cancer Institute



In this paper we explore the ways that management of an ophthalmic emergency varies by the day of the week that it’s diagnosed. With Carolyn Pan Prithvi_Mruthyunjaya and Suzann Pershing



Nice study, as always, Dr. Rishi P. Singh MD

From Ophthalmology: #PrivateEquity in #Ophthalmology & #Optometry: Analysis of Acquisitions from 2012 to 2019 in USA. 228 practices associated w/ 1,466 locations & 2,146 #ophthalmologists or #optometrists were acquired by 29 private equity-backed companies. sciencedirect.com/science/articl…


UM CURE 2020 This is the 10 year anniversary of our discovery that BAP1 loss is the single most important predictor of uveal melanoma metastasis (ncbi.nlm.nih.gov/pubmed/21051595). Our French colleagues are the latest to confirm this and to show that chr 3 loss is only relevant if it includes BAP1.

Read my latest #research on uveal melanoma single cell analysis, published with Springer Nature in Nature Communications. Read and share here: rdcu.be/b0IGC. Bascom Palmer Eye Institute Sylvester Comprehensive Cancer Center #cancer #melanoma #uvealmelanoma #ocularoncology


Excellent work by our #stanfordretina team identifying ongoing disparities in cancer patients. @ByersEye Darius M. Moshfeghi Nitya Rajeshuni Talhah Zubair @cassieludwig Stanford Medicine

Our recommendations from the ASRS for performing #retina surgery during the #COVID19 era. journals.sagepub.com/doi/abs/10.117… berrocalMD Daniel Ting Retina Podcast Charles Wykoff MD Prithvi_Mruthyunjaya

PRP rates for proliferative #diabeticretinopathy declined significantly & anti-VEGF rates significantly increased after publication of Protocol S. Amee Azad, MD MS Ravi Parikh, MD MPH Prithvi_Mruthyunjaya ow.ly/VyiU50AGtUr


Great to work with the talented Ravi Parikh, MD MPH on this study.


AddThis | Home authors.elsevier.com/c/1blkdamCtCtK… Our article on total US expenditures on Ophthalmic care shows overall expenditure is up, but out of pocket is down. We outline factors including rebates, policies, and pricey eye drops. Kudos Ravi Parikh, MD MPH and teams from NYU and Yale

Check out this interesting paper in Ophthalmology written by Ravi Parikh, MD MPH, Prithvi_Mruthyunjaya, Dr. Kristen Nwanyanwu MD, MBA, MHS, and others about changing OOP costs for ophthalmic drugs! #Ophthalmology #MedTwitter #ACA aaojournal.org/article/S0161-… 1/2
